Wolverine Trading’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$7.53M Sell
66,100
-2,000
-3% -$218K 0.01% 1116
2025
Q2
$6.2M Buy
68,100
+35,400
+108% +$2.78M 0.01% 933
2025
Q1
$3.01M Buy
32,700
+18,600
+132% +$1.61M ﹤0.01% 1321
2024
Q4
$1.08M Buy
14,100
+6,800
+93% +$475K ﹤0.01% 2584
2024
Q3
$312K Buy
+7,300
New +$247K ﹤0.01% 3571
2024
Q1
Sell
-13,100
Closed -$36K 5400
2023
Q4
$36K Sell
13,100
-700
-5% -$1.63K ﹤0.01% 4320
2023
Q3
$50.2K Hold
13,800
﹤0.01% 4181
2023
Q2
$88K Buy
13,800
+13,485
+4,281% +$107K ﹤0.01% 3815
2023
Q1
$3K Buy
+315
New +$4.2K ﹤0.01% 4113
2022
Q4
Sell
-485
Closed -$15K 5167
2022
Q3
$15K Sell
485
-291
-38% -$13.3K ﹤0.01% 4411
2022
Q2
$31K Sell
776
-654
-46% -$44.4K ﹤0.01% 4171
2022
Q1
$147K Sell
1,430
-109
-7% -$12.1K ﹤0.01% 4625
2021
Q4
$234K Sell
1,539
-1,034
-40% -$231K ﹤0.01% 4482
2021
Q3
$632K Buy
2,573
+1,518
+144% +$521K ﹤0.01% 3602
2021
Q2
$470K Buy
+1,055
New +$453K ﹤0.01% 3794

Other funds holding WGS

Wolverine Trading's WGS Position: Q3 2025 in Review

Wolverine Trading sold out of GeneDx Holdings (WGS) in Q3 2025, closing a stake of 3,313 shares — an estimated $361K sold.

Wolverine Trading first reported a position in WGS in Q2 2021 and held it in 6 quarters. The position peaked at $857K in Q1 2025. 268 funds tracked by Wall St. Rank hold WGS as of Q3 2025.

  • Wolverine Trading reported no remaining GeneDx Holdings position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 3,313 GeneDx Holdings shares in Q3 2025, an estimated $361K.
  • Wolverine Trading first reported a position in GeneDx Holdings in Q2 2021 and held it in 6 quarters.
  • Wolverine Trading's GeneDx Holdings position peaked at $857K in Q1 2025.
  • 268 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.